Specific Coronary Drug-Eluting Stents Interfere With Distal Microvascular Function After Single Stent Implantation in Pigs  by van den Heuvel, Mieke et al.
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bjectives The aim of this study was to compare the effects of single drug-eluting stents (DES) on
orcine coronary function distal to the stent in vivo and in vitro.
ackground The mechanism of endothelial dysfunction occurring in human coronary conduit arter-
es up to 9 months after DES implantation is unknown.
ethods A sirolimus-eluting stent (SES), paclitaxel-eluting stent (PES), and a bare-metal stent (BMS)
ere implanted in the 3 coronary arteries of 11 pigs. After 5 weeks, in vivo responses in distal coro-
ary ﬂow to different doses of bradykinin (BK) and nitrates were measured. In vitro, vasodilation to
K and nitrates, as well as vasoconstriction to endothelin (ET)-1 were assessed in both distal coro-
ary conduit and small arteries. In addition, contributions of nitric oxide (NO) and endothelium-
erived hyperpolarizing factors (EDHFs) and cyclic guanosine monophosphate (cGMP) responses to
K-stimulation were determined in vitro.
esults Both DES did not alter in vivo distal vasomotion. In vitro distal conduit and small arterial
esponses to BK were also unaltered; DES did not alter the BK-induced increase in cGMP. However,
fter NO synthase blockade, PES showed a reduced BK-response in distal small arteries as compared
ith BMS and SES (p  0.05). The ET-1–induced vasoconstriction and vascular smooth muscle cell
unction were unaltered.
onclusions In this study of single stenting in healthy porcine coronaries for 5 weeks, SES did not
ffect distal coronary vascular function, whereas PES altered distal endothelial function of small ar-
eries under conditions of reduced NO bioavailability. Therefore, speciﬁcally the EDH-component of
icrovascular function seems affected by PES. (J Am Coll Cardiol Intv 2010;3:723–30) © 2010 by
he American College of Cardiology Foundation
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724ercutaneous coronary intervention with stenting is an
stablished treatment in most patients with obstructive
oronary artery disease. Clinical trials have shown that the 2
rst-generation drug-eluting stents (DES), the sirolimus-
luting stent (SES) and paclitaxel-eluting stent (PES),
educe restenosis and revascularization rates by at least 50%
s compared with bare-metal stents (BMS) (1). Despite
eneficial effects of DES on restenosis, coronary endothelial
ysfunction has been observed in areas adjacent to SES
2–4) and PES (5) versus BMS, on average 6 months after
mplantation. This evidence clearly points toward chronic
oronary endothelial dysfunction in the peri-stent area of
onduit arteries after both types of DES-implantation. In
ddition, 9 months after single SES and PES placement,
conduit arterial dysfunction was
shown predominantly in distal
and far distal segments of the
stent (6). This observation sug-
gests that, after single DES, es-
pecially the distal coronary flow
area is at high risk for adverse
effects. However, the exact na-
ture of this distal coronary dys-
function is difficult to study in
clinical settings. Experimental
studies might help to investigate
the underlying mechanism(s) (7).
Overlapping PES implantation
in a porcine model resulted in,
besides distal conduit dysfunction,
abnormal endothelium-dependent
relaxation of distal small arteries
(8). Currently, no data are avail-
able comparing the effects of
single DES on endothelial func-
tion of the coronary microcircu-
lation distal to the stent. In ad-
dition, it is presently unknown
which specific components of
endothelial function might be
articularly affected. This information is important, be-
ause a functional microvascular endothelium plays a key
ole in the regulation of local vascular tone and myocar-
ial perfusion by releasing vasodilating factors, including
itric oxide (NO) and endothelium derived hyperpolar-
zing factors (EDHFs) (9). The latter is believed to be
ore prominent in circumstances of impaired NO-
ediated vasodilatation (10,11).
Consequently, the present study was undertaken to com-
are the effects of single BMS, SES, and PES on distal
oronary function in healthy pigs (12) with focus on the
icrocirculation, in both in vivo and in vitro settings. We
ypothesized that DES implantation would result in distal
bbreviations
nd Acronyms
K  bradykinin
MS  bare-metal stent(s)
GMP  cyclic guanosine
onophosphate
RC  concentration-
esponse curve
ES  drug-eluting stent(s)
DHF  endothelium-derived
yperpolarizing factor
T  endothelin
-NAME  N-nitro-L-arginine
ethyl ester
O  nitric oxide
EC50  concentration
ecessary to produce 50% of
he maximal response
ES  paclitaxel-eluting
tent(s)
ES  sirolimus-eluting
tent(s)
NAP  S-nitroso-N-
cetylpenicillaminendothelium-dependent microvascular dysfunction, evi- nenced by decreased vasodilation and increased vasocon-
triction. Specifically, we focussed on the NO and EDHF
omponents of vascular function.
ethods
oronary intervention. Eleven Yorkshire-Landrace pigs of
ither sex (57  4 kg at implantation; 75  7 kg at death)
ntered the study. The study was performed in accordance
ith the Guide for Care and Use of Laboratory Animals
National Institutes of Health Publication No. 85-23,
evised 1996), after approval of the local Animal Ethics
ommittee.
Animal preparation and stent implantation were per-
ormed as described previously (12). In short, 1 day before
urgery animals received 300-mg acetylsalicylic acid and a
oading dose of 300-mg clopidogrel. Under general anes-
hesia, left and right coronary angiography were performed
o select arterial segments of 2.5 to 3.5 mm in diameter in
he left anterior descending, left circumflex, and right
oronary arteries. Three types of commercially available
tents were randomly implanted in selected uninjured cor-
nary segments with a balloon/artery ratio of 1:1, such that
ach animal received all stents (1 stent/coronary artery) in a
andom fashion: a BMS (R-stent Evolution/Prodigy, 316L
tainless steel stent, 15-mm length, 3.0- to 3.5-mm diam-
ter, Orbus MT, Fort Lauderdale, Florida), a SES (Cypher:
ES with 1.4-g/mm2 sirolimus-loading, 316L stainless
teel stent, 13-mm length, 3.0- to 3.5-mm diameter, Cor-
is, Miami, Florida), and a PES (Taxus: DES with 1.0-g/
m2 paclitaxel-loading, 316L stainless steel stent, 12-mm
ength, 3.0- to 3.5-mm diameter, Boston Scientific, Natick,
assachusetts). After repeat angiography, the animals were
llowed to recover and followed for 5 weeks. This period is
elieved to result in maximal neointimal thickness after
MS implantation in animals, comparable to the response
t 6 to 9 months in patients (13). During follow-up, the
nimals received 300-mg acetylsalicylic acid and 75-mg
lopidogrel daily.
n vivo coronary function assessment. After 5 weeks,
hanges in coronary flow velocities distal to the stent
nduced by different agonists were measured with a Doppler
ipped guidewire (FloWire, Volcano Therapeutics, Inc.,
ancho Cordova, California). Intracoronary flow velocity
easurements were performed continuously, both at stable
aseline hemodynamic status and during intracoronary in-
usion of the endothelium-dependent vasodilator bradyki-
in (BK) (0.05 to 1.0 g/kg/min), the endothelium-
ndependent vasodilating agent sodium nitroprusside (5 to
0 g/kg/min), and at maximal vasodilation to adenosine
100 g/kg/min) (14,15). The alpha1-adrenoceptor agonist
henylephrine was co-infused to maintain mean arterial
ressure at approximately 90 mm Hg, while leaving coro-
ary microvascular tone unperturbed (15). Each agonist
c
5
fl
c
b
T
f
c
m
s
s
d
a
f
b
I
S
w
S
w
A
c
s
w
c
i
r
p
(
-
s
r
o
i
F
1
f
v
(
C
B
d
s
e
w
w
a
H
a
r
t
i
d
D
v
v
p
a
f
m
p
C
w
E
t
s
d
l
v
R
P
p
m
a
i
s
p
t
t
l
1
E
f
d
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 3 , N O . 7 , 2 0 1 0 van den Heuvel et al.
J U L Y 2 0 1 0 : 7 2 3 – 3 0 DES and Microcirculation
725oncentration was maintained for 3 min, followed by a
-min washout period to allow for restoration of baseline
ow. The peak-increase in distal coronary flow velocity was
alculated for each concentration as maximum minus
aseline.
issue collection. All pigs were killed after 5 weeks of
ollow-up. Hearts were immediately excised and collected in
old, oxygenated Krebs bicarbonate buffer (16,17). Seg-
ents of epicardial conduit arteries (2 mm diameter),
tarting approximately 0.5 cm distal to the stent and
egments of epicardial small arteries (approximately 300 m
iameter) in the specific distal flow area of the stented
rtery, were isolated and placed in buffer for in vitro
unctional studies. The stented segment was placed in 4%
uffered formaldehyde for histology.
n vitro coronary conduit and small arterial function assessment.
egments of conduit arteries (approximately 4 mm length)
ere suspended on stainless steel hooks in organ baths.
egments of small arteries (approximately 2 mm length)
ere mounted in a Mulvany wire myograph (DMT A/S,
arhus, Denmark). Vascular responses were measured as
hanges in isometric force (16,17).
Both conduit and small arteries were subjected to the
ame experimental protocol. After stabilization, segments
ere exposed to depolarization by 0.1 mol/l potassium
hloride. Upon wash-out of potassium chloride, after equil-
bration, in a first set of segments, endothelium-dependent
elaxation to BK (1010 to 106 mol/l) was recorded upon
re-constriction with the thromboxane analogue U46619
108 to 107 mol/l). To determine NO-dependent and
independent contributions to BK-induced relaxation, in a
econd set of pre-constricted segments, the concentration-
esponse curve (CRC) for BK was constructed after 30 min
f pre-incubation with 104 mol/l of the NO-synthase
nhibitor N-nitro-L-arginine methyl ester (L-NAME).
rom a third set, CRCs for endothelin (ET)-1 (1010 to
07 mol/l) were constructed to study vasoconstriction,
ollowed by endothelium-independent but NO-mediated
asodilation to S-nitroso-N-acetylpenicillamine (SNAP)
107 to 106 mol/l).
yclic guanosine monophosphate measurements. To study
K-induced cyclic guanosine monophosphate (cGMP) pro-
uction, segments of small arteries distal to the stent of a
ubset of pigs (n 5) were nonexposed (control subjects) or
Table 1. QCA Assessment of Coronary and Procedural Characteristics at th
Group Pre-Stenting (mm) Post-Stenting (mm)
BMS (n  10) 3.02 0.09 3.15 0.10
SES (n  10) 3.13 0.11 3.29 0.09
PES (n  11) 3.19 0.10 3.37 0.11
Pre- and post-stenting: mean coronary lumen diameter at site of intervention before and directly a
inflation pressure: maximal inflation pressure used for stent placement.BA balloon-to-artery; BMS bare-metal stent(s); PES paclitaxel-eluting stent(s); QCA quantitativxposed to BK (106 mol/l) with or without pre-incubation
ith L-NAME (104 mol/l). The cGMP concentrations
ere determined by enzyme-linked immunoadsorbent assay
nd expressed as pmol  mg1 protein (17).
istology. Fixed stented segments were plastic embedded
nd stained with hematoxylin-eosin (routine stain) and
esorcin-fuchsin (elastin stain) for quantitative and qualita-
ive analysis. Neointimal thickness at the stent struts and
nflammation scores directly adjacent to the struts were
etermined (12).
ata analysis. Differences between the stent-types of indi-
idual outcome variables (procedural, histology data, single
ascular function data, and the like) were assessed with
aired t tests with correction for multiple testing. Statistical
nalysis of logarithmic vascular function CRCs was per-
ormed with a nonlinear mixed-effects model fit by maxi-
um likelihood with nested random effects (statistical
rogram R, version 2.10.1, The R Foundation for Statistical
omputing, Wien, Austria).
In vitro vascular relaxant responses to BK and SNAP
ere expressed as percentage of contraction to U46619 and
T-1, respectively. Constrictor responses were normalized
o 0.1 mol/l potassium chloride. The concentration neces-
ary to produce 50% of its maximal response (pEC50) was
etermined for each CRC reaching a maximum, with
ogistic function (16,17). Data are given as mean SEM. A
alue of p  0.05 was considered statistically significant.
esults
rocedural characteristics. Quantitative coronary angiogra-
hy analysis of selected segments revealed no differences in
ean coronary diameter of the 3 stent groups, both before
nd immediately after stenting. Also, procedural character-
stics showed no differences in mechanical vessel injury at
tent implantation (Table 1). Furthermore, in a subset of
igs (n  5), quantitative coronary angiography analysis of
he stented segments was performed 5 weeks after implan-
ation. No significant differences in percentage late lumen
oss were observed (BMS vs. SES, PES: 16.8  3.4% vs.
7.7  5.5%, 6.9  1.5%; p  NS).
ffects of DES on distal coronary conduit and small arterial
unction. IN VIVO ASSESSMENT. During flow measurements
istal to the stent, no significant changes occurred in heart
e of Stent Implantation
alloon Size (mm) Max Inflation Pressure (atm) BA-Ratio
3.30 0.09 13.4 1.5 1.09 0.01
3.35 0.10 14.4 1.1 1.07 0.03
3.49 0.11 14.9 1.2 1.09 0.01
t placement. Balloon size: mean diameter of contrast-filled balloon during maximal inflation. Maxe Tim
B
fter stene coronary angiography; SES sirolimus-eluting stent(s).
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726ate (85  2 beats/min) and mean arterial pressure (92  3
m Hg) at baseline or during infusion of BK, sodium
itroprusside, or adenosine. Also, no significant differences
n distal vasodilatory responses to BK, sodium nitroprusside,
r adenosine were reported after 5 weeks of BMS, SES, and
ES implantation (Fig. 1).
N VITRO ASSESSMENT. Contractile responses to potassium
hloride and pre-constriction to U46619 were similar be-
ween stent types, both for conduit and small arteries (data
ot shown).
ONDUIT ARTERIES. Segments of coronary conduit arteries
istal to the stent dilated to BK in a dose-dependent
anner (pEC50 BMS vs. SES vs. PES: 8.2  0.2 vs. 8.0 
.3 vs. 8.0  0.1). Relaxations corresponded with approxi-
ately 70% of the pre-constriction level by U46619, with no
ifferences between the different stents (Fig. 2A). Pre-
reatment with L-NAME greatly reduced dilation to BK
p  0.01, L-NAME vs. no L-NAME for all stent-types).
he effect of L-NAME was not different between the stents
Fig. 2B). The compound ET-1–induced vasoconstriction
n a concentration-dependent manner to 100% of the
esponse to 0.1 mol/l potassium chloride (pEC50 BMS vs.
ES vs. PES: 7.5  0.1 vs. 7.7  0.1 vs. 7.5  0.1). This
ffect was not significantly altered by either SES or PES
Fig. 2C). The exogenous NO-donor SNAP resulted in
asodilation similar for all stent types (Fig. 2D).
MALL ARTERIES. Segments of coronary small arteries dis-
al to the stent dilated to BK in a concentration-dependent
anner (pEC50 BMS vs. SES vs. PES: 8.3  0.2 vs. 8.2 
.2 vs. 8.0  0.1). Relaxations amounted up to 90% of the
re-constriction level and were influenced by stent-type
Fig. 2E), in that chronic PES implantation caused a
Figure 1. In Vivo Coronary Function
Effects of 5 weeks of single stents on baseline (BL), endothelium-dependent (b
side [SNP]) peak increases in coronary ﬂow velocity (CFV) of the distal coronar
ing stent(s); SES  sirolimus-eluting stent(s).odest rightward shift of the BK-CRC (p  0.01, PES vs.
ES; p  0.1, PES vs. BMS) (Fig. 2E). After pre-
ncubation with L-NAME, the BK-CRC was clearly
hifted to the right (p  0.01, L-NAME vs. no L-NAME
or all stent-types) (Fig. 2F). The effect of L-NAME in
mall arteries was more modest than in conduit arteries.
his confirms that the NO-independent component of the
K response in small arteries is more pronounced than in
onduit arteries (16,17). The PES implantation shifted the
K-CRC in the presence of L-NAME approximately 10
imes to the right as compared with BMS and SES (p 
.02, PES vs. BMS; p  0.02, PES vs. SES) (Fig. 2F).
hus, small arteries distal of PES showed impaired vasodi-
ation upon incubation with L-NAME (pEC50 BMS vs.
ES vs. PES: 7.6  0.3 vs. 7.9  0.2 vs. 7.0  0.3). The
ES-type of stent specifically reduced the NO-independent
omponent of the BK response. The compound ET-1–
nduced vasoconstriction in a concentration-dependent
anner up to 150% of the response to 0.1 mol/l potassium
hloride (pEC50 BMS vs. SES vs. PES: 7.7  0.1 vs. 7.6 
.1 vs. 7.6  0.1), unaffected by stent-type (Fig. 2G). The
xogenous NO-donor SNAP resulted in vasodilation of the
mall arteries similar for all stent-types, indicating intact
ascular smooth muscle cell function (Fig. 2H).
yclic GMP measurements in distal small arteries. After
K-stimulation, distal microvascular cGMP levels were 1.95
0.5 to 11.9) pmol  mg1, 1.01 (0.2 to 2.3) pmol  mg1,
nd 1.63 (0.6 to 7.7) pmol  mg1 protein (geometric
ean and range of BMS vs. SES vs. PES; p  NS).
re-incubation with L-NAME reduced the microvascular
GMP content after BK-stimulation by 80.4  7.7% vs.
1.8  22.3% vs. 73.0  6.3%, respectively (p  NS).
inin [BK]), adenosine (ADO) and endothelium-independent (sodium nitroprus-
lation in vivo (n  5 pigs). BMS  bare-metal stent(s); PES  paclitaxel-elut-radyk
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727hese results agree with previously published data on
K-stimulated porcine coronary small arteries (17).
istology of stented coronary arteries. Qualitative analysis
howed that the vascular response after stenting followed
atterns typical for BMS (Fig. 3A) and DES (Figs. 3B
nd 3C) in pigs (12). The neointima in BMS consisted of
ascular smooth muscle-like cells within a collagenous
atrix largely covered by endothelial cells. The neoin-
ima in DES was similar, including the presence of
ndothelial cells in all DES. Typically for DES, the
eointima also contained fibrinoid deposition—a marker
f delayed healing (18)—surrounding the stent struts
Figs. 3B and 3C). In PES, mitotic figures characteristic
or paclitaxel were observed (Fig. 3C), whereas SES
howed more inflammation resulting in increased neoin-
imal formation on top of the struts (BMS vs. SES vs.
ES: 313  49.3 m vs. 524  82.9 m vs. 268  36.0
m; p  0.01 SES vs. PES). Neointimal thickness was
ot significantly different among the groups upon exclu-
ion of stents with a high inflammation score (BMS vs.
ES vs. PES: 313  49.3 m vs. 355  58.2 m vs.
35  16.6 m; p  NS).
iscussion
n the present study, we compared the effects of first-
eneration DES on endothelial function of the distal
Figure 2. In Vitro Coronary Conduit Arterial Function and In Vitro Coronary
Effects of 5 weeks of single stents on distal endothelium-dependent (BK, BK af
independent vasodilation (S-nitroso-N-acetylpenicillamine [SNAP]), and vaso
in vitro (n  11 pigs). Top panels: conduit arteries; bottom panels: small
SES); CRCs to BK after pre-incubation with L-NAME (B, F: †p  0.02, PES vs
Abbreviations as in Figure 1.oronary vasculature with special focus on the microcircu- Dation, in both in vivo and in vitro settings in healthy pigs.
e hypothesized that DES implantation would result in
istal endothelial dysfunction evidenced by decreased vaso-
ilation and increased vasoconstriction. The main findings
ere that after 5 weeks of DES implantation, in vivo
ascular function distal to DES was essentially unaffected.
his was confirmed in vitro, because SES implantation did
ot alter BK-mediated vasodilation, whereas PES had only
odest effects. However, under conditions of reduced NO
ioavailability, PES-induced defects in distal microvascular
unction in vitro were clearly exposed. These defects were
rincipally due to impairment of the NO-independent
omponent of BK-induced vasodilation. Specifically, endo-
helial function was affected, because the vasodilation re-
ponse to an exogenous NO donor was unaltered. The
ES-type of stent did not alter the cGMP response upon
K stimulation in vitro, the key second messenger system of
O-dependent vasodilation, a finding in agreement with
he vascular function results.
ES effects on distal coronary function. This study indicates
or the first time that the effects of single DES might extend
nto the distal coronary microcirculation of healthy pigs.
his conclusion is based on results obtained in vitro in
solated coronary small arteries. Five weeks after stenting,
icrovascular alterations are not primarily induced by cir-
ulating concentrations of DES drugs, because 30 days after
Arterial Function
e-incubation with N-nitro-L-arginine methyl ester [L-NAME]), endothelium-
riction (endothelin [ET]-1) of coronary conduit arteries and small arteries
s. Concentration-response curves (CRCs) to BK (A, E: p  0.01, PES vs.
; ‡p  0.02, PES vs. SES); CRCs to ET-1 (C, G); CRCs to SNAP (D, H).Small
ter pr
const
arterie
. BMSES placement, drug-release from the stent is minimal (1).
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728n addition, in-stent histology showed neointimal healing
or all groups, thereby minimizing ongoing drug release in
he circulation.
A recent pig study already showed abnormal endothelium-
Figure 3. In Stent Histology
Representative in-stent histological sections. The BMS shows a well-healed
neointima with vascular smooth muscle cells in a collagenous matrix (A);
SES shows less cellularity and moderate amounts of ﬁbrinoid (red) (B); PES
also shows ﬁbrinoid surrounding the stent struts as well as mitotic spindles
(C, magniﬁcations). All stents were largely covered by endothelium (hema-
toxylin-eosin stain; bar  100 m; magniﬁcation inserts: 2 original
image; white squares: areas of magniﬁcation). Abbreviations as in Figure 1.ependent relaxation of distal small arteries after 1 month of txposure to PES (8). However, in this study overlapping
ES were implanted, creating a more profound local injury
nd inflammatory reaction contributing to the vasomotor
ysfunction in the peri-stent area as compared with the
resent study. Furthermore, with overlapping DES
mplantation, additional drug concentrations will be eluted
rom the stents, aggravating local side effects. The authors
eported a decreased NO-mediated conduit arterial re-
ponse adjacent to overlapping PES, most likely due to
ocally enhanced oxidative stress. However, the mechanisms of
he impaired small arterial responses of the distal perfusion bed
ere not examined. Of note, the reported abnormal
ndothelium-dependent relaxation of distal small arteries did
ot result in enhanced ET-1–induced vasoconstriction (8).
In the present study no clear differences were observed in
istal microvascular functions with BK alone or with
NAP, either in vivo or in vitro. Only after NO synthase
lockade in vitro, significant differences were demonstrated
n microvascular responses of PES-treated coronary arteries.
his suggests that PES specifically affected the NO-
ndependent component of BK-induced microvascular en-
othelial vasodilation (i.e., EDHF) (17). Classically, this
DHF component can be blocked by applying inhibitors of
mall and intermediate conductance calcium-dependent po-
assium channels (apamin and charybdotoxin) (17). Prelim-
nary data from our laboratory confirm that adding apamin
nd charybdotoxin on top of L-NAME fully blocked the
icrovascular BK-response after chronic DES-implantation
data not shown). The EDHFs are known to be of partic-
lar importance in small arteries, although their exact
olecular mechanisms and pathways remain to be unrav-
lled (16,17,19,20). In agreement with an alteration in
DHF and not in NO, the cGMP-response—the key
econd messenger system of NO—was unaltered by PES
n vitro. The PES did not affect ET-1–induced micro-
ascular constriction, possibly because NO and ET-1 are
alanced (21).
The exact molecular mechanisms by which 5 weeks of
ingle PES resulted in alterations of distal EDHF-mediated
icrovascular function cannot be derived from the present
tudy. However, it is of interest to note that, although both
ES reduce restenosis rates effectively (1), they have dif-
erent mechanisms of action (18). Accumulation of extra-
ellular reactive oxygen species is a crucial step for
aclitaxel-induced cancer cell death (22). In addition, over-
apping PES implantation was associated with enhanced
ocal oxidative stress affecting NO-mediated vasodilation of,
n particular, conduit arteries in the peri-stent area (8).
owever, reactive oxygen species increase—in particular, a
ise in hydrogen peroxide—also has been reported to in-
ibit EDHF-synthesis by cytochrome P450 epoxygenases
17,23,24). Therefore, local vascular accumulation of pacli-
axel might give rise to local oxidative stress, modifying
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729pecific components of endothelial function, perhaps de-
ending on the affected vessel size.
linical studies. The in vivo observations of the current
tudy, made in conduit arteries immediately distal to both
ES, showed unaffected vascular function. These observa-
ions contrast with clinical studies reporting coronary endo-
helial dysfunction up to 9 months after DES implantation
2–6). An explanation for this discrepancy could involve
ifferent study time-frames, protocols, and the use of
ealthy porcine vessels. First, stent healing in healthy pigs is
uch faster as compared with diseased patients. Although
he results obtained in pigs after 5 weeks of stenting might
orrelate to patient results obtained 6 to 9 months after
tenting, one should be cautious with extrapolation of
ES-results (13). Second, in contrast to human coronary
rteries, porcine coronaries respond poorly to acetylcholine
s an agonist, due to limited presence of muscarinic recep-
ors within the vascular wall. Although the acetylcholine
esponse is a hallmark in the detection of impaired coronary
ndothelial function in patients, BK-induced endothelium-
ependent vasodilation is clinically relevant as well (25).
inally, in the clinical setting severely diseased vessels are
tented instead of the healthy, uninjured coronary arteries of
he pigs of the present study. Obviously, in patients,
ndothelial vulnerability of conduit arteries might have
xisted before stenting, and this might explain why an
mpaired conduit endothelial response after DES implanta-
ion was already observed in humans without NO synthase
lockade, whereas in healthy pigs it could only be observed
n the more sensitive small arteries in the presence of
-NAME.
tudy limitations. In the present study, part of the experi-
ents were performed in an in vitro setting. Although in
itro not all the influencing factors of in vivo are present,
his specifically allowed us to examine vascular responses
ith and without NO bioavailability in the DES-exposed
oronary vessels of each animal. In the in vivo setting, such
n extensive vasoactive protocol would be hampered both by
he potential systemic effects of NO blockade as well as
K-induced tachyphylaxis, which needs to be taken into
ccount when studying vasomotion with and without NO
lockade.
Additionally, the present study reports the in vitro results
f PES in a relatively limited number of pigs that was large
nough to show clear changes like the microvascular re-
ponse to BK after pre-incubation with L-NAME but
ight have been too low to draw conclusions on the basis of
small difference such as the microvascular response to BK.
onclusions
e compared the functional effects of first-generation
ingle DES on the distal coronary circulation. Particularly
ES might show distal endothelium-dependent microvas-ular dysfunction, because the loss of local EDHF-mediated
asodilation eventually might alter the vasomotor balance
nd therefore local myocardial perfusion in the in vivo
etting. Our results might be relevant for vulnerable coro-
ary artery disease patients with severe microvascular endo-
helial dysfunction, given their already existing reduced
icrovascular NO-bioavailability. However, the in vitro
bservations of the present study warrant further studies to
xamine distal vascular alterations caused by PES over time
n more detail as well as at longer follow-up.
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